Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 41 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Riley C.

United States

USD 41 /hr

Neuroscience PhD and science communicator helping researchers turn their science into stories.

Profile Summary

I spent seven years studying neurodegeneration at some of the country’s premier research institutions – Massachusetts General Hospital, Washington University in St. Louis, and Johns Hopkins University, where I earned my PhD in neuroscience. I published nine peer-reviewed publications, was awarded a grant from the National Science Foundation, and presented posters at multiple international conferences. But while I enjoyed my time at the bench, I found that my strength was in communicating science rather than conducting it. I established a free editing network at Johns Hopkins and oversaw the editing of over 100 manuscripts, grants, reviews, book chapters, and other technical documents. In my free time, I launched an international podcast and became a freelance science writer. I also earned a Medical Writing Essential Skills certification from the American Medical Writers Association, where I am a member.

Subject Matter Expertise

• ★ Cell Biology
• ★ Molecular Neuroscience
• ★ Neurobiology
• ☆ Cell Signaling Pathways
• ☆ Neuroscience
• ☆ Basic Immunology
• ☆ Adjuvant & Antigen Research
• ☆ Cell Aging

Services

• Writing

Writing Medical Writing, Technical Writing, Copywriting, General Proofreading & Editing

Work Experience

Grant Specialist

Will of Iron Foundation

December 2024 - Present

Freelance medical writer and editor

Riley Catenacci Medical Communications

December 2024 - Present

Graduate Student (Ph.D.)

Johns Hopkins University School of Medicine

September 2019 - August 2024

Editor-in-Chief

JHU ReVision

April 2020 - January 2024

Blog Content Writer

Sparrow Science

September 2022 - October 2023

Research Technician

Washington University in St. Louis

July 2018 - December 2018

Undergraduate Research Assistant

Massachusetts General Hospital

July 2017 - April 2018

Education

PhD, Neuroscience

Johns Hopkins University

August 2019 - August 2024

BS, Behavioral Neuroscience

Northeastern University

September 2015 - May 2019

Certifications

• Essential Skills in Medical Writing

  American Medical Writers Association

  https://info.amwa.org/medical-communication-essential-skills-for-success

  October 2024 - Present

• SciComm Essentials

  Kavli Institute

  https://community.kavlimeetings.org/science-and-society/

  September 2024 - Present

Publications

JOURNAL ARTICLE

Larissa Jank, Riley B. Catenacci, Veronica Minney, Danny Galleguillos, Peter A. Calabresi (2024). Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro . Neurotherapeutics.

Cole A Harrington, Riley B Catenacci, Matthew D Smith, Dongeun Heo, Cecilia Miller, Keya R Meyers, Jenna Glatzer, Dwight Bergles, Peter A Calabresi (2023). MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis . eLife.

Marjan Gharagozloo, Riley Bannon, Peter A. Calabresi (2022). Breaking the barriers to remyelination in multiple sclerosis . Current Opinion in Pharmacology.

Simon Dujardin, Analiese R. Fernandes, Riley Bannon, Caitlin Commins, Mark De Los Santos, Tarun V. Kamath, Mansuo Hayashi, Bradley T. Hyman (2022). Tau propagation is dependent on the genetic background of mouse strains . Brain Communications.

Kathleen Schoch, Lubov Ezerskiy, Michaela M. Morhaus, Riley N. Bannon, Andrew D. Sauerbeck, Mark Shabsovich, Paymaan Jafar-nejad, Frank Rigo, Timothy Miller (2021). Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice . Proceedings of the National Academy of Sciences.

Marjan Gharagozloo, Matthew D. Smith, Elias S. Sotirchos, Jing Jin, Keya Meyers, Michelle Taylor, Thomas Garton, Riley Bannon, Hannah-Noelle Lord, Ted M. Dawson, et al. (2021). Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis . Neurotherapeutics.

Susanne Wegmann, Sarah DeVos, bryan zeitler, Kim Marlen, Rachel Bennett, Marta Perez-Rando, Danny MacKenzie Jr, Qi Yu, Caitlin Commins, Riley N. Bannon, et al. (2021). Persistent repression of tau in the brain using engineered zinc finger protein transcription factors . Science Advances.

Sarah L DeVos, Bianca T Corjuc, Caitlin Commins, Simon Dujardin, Riley N Bannon, Diana Corjuc, Benjamin D Moore, Rachel E Bennett, Mehdi Jorfi, Jose A Gonzales, et al. (2018). Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo . Brain.

Sarah L. DeVos, Bianca T. Corjuc, Derek H. Oakley, Chloe K. Nobuhara, Riley N. Bannon, Alison Chase, Caitlin Commins, Jose A. Gonzalez, Patrick M. Dooley, Matthew P. Frosch, et al. (2018). Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain . Frontiers in Neuroscience.